These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7183241)

  • 1. [Induction of pulmonary thrombosis in the rat by i.v. injections of ADP and the antithrombotic activity of triflusal].
    Ramis J; Sánchez MS; García Rafanell J; Forn J
    Arch Farmacol Toxicol; 1982 Dec; 8(3):111-6. PubMed ID: 7183241
    [No Abstract]   [Full Text] [Related]  

  • 2. [Induction of pulmonary thrombosis in mice, rabbits and hamsters by intravenous injection of arachidonic acid. Comparative study of 3 experimental models in vivo and the antithrombotic activity of triflusal].
    García Rafanell J; Bellés L; Forn J
    Arch Farmacol Toxicol; 1979 Dec; 5(3):193-8. PubMed ID: 546338
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of chronic administration of triflusal on pulmonary thrombosis induced by arachidonic acid].
    Ramis J; Sánchez MS; García Rafanell J; Forn J
    Arch Farmacol Toxicol; 1982 Dec; 8(3):117-22. PubMed ID: 6820762
    [No Abstract]   [Full Text] [Related]  

  • 4. Protective effects of triflusal on secondary thrombus growth and vascular cyclooxygenase-2.
    Duran X; Sánchez S; Vilahur G; Badimon L
    J Thromb Haemost; 2008 Aug; 6(8):1385-92. PubMed ID: 18503633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant and antithrombotic activity of a new peptide pENW (pGlu-Asn-Trp).
    Xiong J; Fang W; Fang W; Bai L; Huo J; Kong Y; Yunman L
    J Pharm Pharmacol; 2009 Jan; 61(1):89-94. PubMed ID: 19126301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonist.
    Berry CN; Lorrain J; Lochot S; Delahaye M; Lalé A; Savi P; Lechaire I; Ferrari P; Bernat A; Schaeffer P; Janiak P; Duval N; Grosset A; Herbert JM; O'Connor SE
    Thromb Haemost; 2001 Mar; 85(3):521-8. PubMed ID: 11307825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic strain differences in platelet aggregation and thrombus formation of laboratory rats.
    Sudo T; Ito H; Hayashi H; Nagamura Y; Toga K; Yamada Y
    Thromb Haemost; 2007 Apr; 97(4):665-72. PubMed ID: 17393031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vintoperol on platelet aggregation and experimental thrombosis.
    Csomor K; Kárpáti E
    Arzneimittelforschung; 1994 Jan; 44(1):36-40. PubMed ID: 8135876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antithrombotic activity of para-aminobenzoic acid].
    Drozd NN; Makarov VA; Miftakhova NT; Kalugin SA; Stroeva OG; Akberova SI
    Eksp Klin Farmakol; 2000; 63(3):40-4. PubMed ID: 10934595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of triflusal on platelet activation after coronary artery bypass graft.
    Prieto MA; De La Cruz JP; Del Prado MF; Sánchez de la Cuesta F
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):191-7. PubMed ID: 10759013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic activity of N,N-dichlorotaurine on mouse model of thrombosis in vivo.
    Murina MA; Fesenko OD; Sergienko VI; Chudina NA; Roshchupkin DI
    Bull Exp Biol Med; 2002 Jul; 134(1):36-8. PubMed ID: 12459864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor.
    Lorrain J; Millet L; Lechaire I; Lochot S; Ferrari P; Visconte C; Sainte-Marie M; Lunven C; Berry CN; Schaeffer P; Herbert JM; O'Connor SE
    J Pharmacol Exp Ther; 2003 Feb; 304(2):567-74. PubMed ID: 12538808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical and clinical studies with selective reversible direct P2Y12 antagonists.
    van Giezen JJ; Humphries RG
    Semin Thromb Hemost; 2005 Apr; 31(2):195-204. PubMed ID: 15852223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lauric acid-induced thrombocytopenia and thrombosis in rabbits.
    Zbinden G
    Thromb Diath Haemorrh; 1967 Aug; 18(1-2):57-65. PubMed ID: 6066605
    [No Abstract]   [Full Text] [Related]  

  • 15. Antithrombotic and thrombolytic activity of heparins in a rat model of laser-induced thrombosis.
    Krupiński K; Giedrojć J; Breddin HK; Bielawiec M
    Pol J Pharmacol; 1996; 48(3):345-50. PubMed ID: 9112675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibition of platelet cyclo-oxygenase by triflusal].
    Sánchez MS; Ramis J; García Rafanell J; Forn J
    Arch Farmacol Toxicol; 1982 Dec; 8(3):193-6. PubMed ID: 6820763
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-thrombotic effect of a PAI-1 inhibitor in rats given endotoxin.
    Abrahamsson T; Nerme V; Strömqvist M; Akerblom B; Legnehed A; Pettersson K; Westin Eriksson A
    Thromb Haemost; 1996 Jan; 75(1):118-26. PubMed ID: 8713790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computerized optoelectronic induction and registration of arterial thrombosis.
    Bourgain RH
    Methods Find Exp Clin Pharmacol; 1990 May; 12(4):257-63. PubMed ID: 2374473
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antithrombotic activity of complexes of superoxide dismutase with chondroitin sulfate in arterial damage in rats].
    Maksimenko AV; Tishchenko EG; Golubykh VL
    Vopr Med Khim; 1998; 44(4):353-61. PubMed ID: 9845922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental pharmacology of hirunorm: a novel synthetic peptide thrombin inhibitor.
    Cirillo R; Lippi A; Subissi A; Agnelli G; Criscuoli M
    Thromb Haemost; 1996 Sep; 76(3):384-92. PubMed ID: 8883275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.